WeVote
Log In

Bill

Bill

SF 1167

Maternal death studies requirements clarification

2025-2026 Regular Session Introduced by Julia Coleman and 4 co-sponsors

SF 1167 clarifies and standardizes maternal death study rules, defining data collection, roles, timelines, and privacy protections for health agencies, providers, and families.

Referred to Health and Human Services
#datapracticesandprivacy #healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · SF 1167

Summary of SF 1167 — Maternal death studies requirements clarification

Overview

SF 1167, titled “Maternal death studies requirements clarification,” is a Minnesota Senate bill introduced on February 10, 2025. The bill has been referred to the Health and Human Services committee. A companion bill is HF 1105. The subject areas listed include Data Practices and Privacy and Health and Health Department.

Purpose and Intent

  • The bill’s title indicates that it seeks to clarify existing requirements related to maternal death studies. While the full text is not provided here, the intent appears to be to tighten or standardize the scope, process, and governance of maternal death investigations and associated data practices.
  • Likely aims include ensuring consistency in how maternal death data are collected, analyzed, and reported, and aligning study requirements with privacy and data practices laws.

Key Provisions (based on the title; text not provided)

  • Clarification of statutory requirements for maternal death studies (e.g., who conducts studies, what data are collected, and what methodologies are required).
  • Specification of roles and responsibilities of agencies (likely including the Minnesota Department of Health) involved in maternal death investigations.
  • Data handling and privacy considerations under the Minnesota Data Practices framework (e.g., access, confidentiality, retention, and disclosure of maternal death data).
  • Timelines, reporting requirements, and potential standards or benchmarks for the completion of studies.
  • Alignment or coordination with related health surveillance activities.

Note: The exact provisions are not included in the provided materials. The bullets above reflect plausible components inferred from the bill’s title and subject areas.

Affected Parties

  • State agencies overseeing maternal health surveillance and death investigations (notably the Department of Health).
  • Healthcare providers, hospitals, and public health partners involved in maternal death data collection or case review.
  • Researchers and public health professionals conducting maternal death studies.
  • Individuals and families impacted by maternal death data, with privacy protections governed by data-practices laws.

Procedural History and Timeline

  • Introduction and first reading: February 10, 2025.
  • Referred to: Health and Human Services committee.
  • Related bill: HF 1105 (companion).

Potential Impacts and Considerations

  • Pros: Greater clarity and consistency in how maternal death studies are conducted; improved alignment with data privacy protections; smoother interagency coordination and reporting.
  • Cons: Potential compliance costs or administrative adjustments for agencies; need for careful balance between transparency and privacy depending on data sensitivity.

Next Steps

  • Monitor committee hearings and any amendments to SF 1167.
  • Compare SF 1167 with HF 1105 for a fuller understanding of proposed changes and consensus between the companion bills.
  • Review the bill text when available to assess precise provisions, timelines, and any funding or implementation requirements.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.